Objective: To investigate the benefit of botulinum toxin type A injection into the ankle plantarflexor muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
Design: Case-control study.
Setting: Inpatients in a university-affiliated hospital.
Subjects: Forty spastic diplegic children aged from 2 to 6 years (18 children with botulinum toxin type A injection into both gastrocnemius muscles as an experimental group and 14 children without injection as a control group).
Main measures: Sit-to-stand transfer task was evaluated using a motion analyser (Vicon 370 MA with six infrared cameras). The tests were performed twice with a two-week interval. The changes in temporal, kinematic and kinetic parameters were investigated in each group.
Results: In the control group there were no significant changes in any of the measured parameters between the tests. In the experimental group, total duration (s) of sit-to-stand transfer was shortened after injection (4.359 ± 2.49 to 2.899 ± 1.48, P < 0.05). The maximal angles (degrees) of pelvic and hip joints were reduced (28.889 ± 5.53 to 26.579 ± 3.73 and 90.789 ± 8.69 to 87.239 ± 8.76) and the initial angle of ankle dorsiflexion was increased (4.419 ± 6.16 to 7.089 ± 6.09) after injection (P < 0.05). The maximal moments (Nm/kg) of the hip and knee joints (0.449 ± 0.17 to 0.519 ± 0.21 and 0.139 ± 0.05 to 0.189 ± 0.14) were increased while that of the ankle joint was reduced (0.329 ± 0.09 to 0.289 ± 0.10) after injection (P < 0.05). Only the cases with greater reduction of spasticity showed an improvement on kinematic and kinetic parameters.
Conclusion: Botulinum toxin type A injection into spastic ankle plantarflexors led to better accomplishment of sit-to-stand transfer in children with spastic diplegic cerebral palsy.
Get full access to this article
View all access options for this article.
References
1.
Riley PO, Schneckman ML, Mamm RW, Hodge RW, Hodge WA. Mechanics of a constrained chair-rise. J Biomech1991; 24: 77-85.
2.
Su FC, Lai KA, Hong WH. Rising from chair after total knee arthroplasty. Clin Biochem1998; 13: 176-181.
3.
Bahrami F, Reiner R, Jabedar-Maralani P, Schmidt G.Biomechanical analysis of sit-to-stand transfer in healthy and paraplegic subjects. Clin Biomech2000; 15: 123-133.
4.
Hennington G, Johnson J, Penrose J, Barr K, McMulkin ML, Vander Linden DW. Effect of bench height on sit-to-stand in children without diabilities and children with cerebral palsy. Arch Phys Med Rehabil2004; 85: 70-76.
5.
Wilson H, Harideri N, Song K.Telford D.Ankle-foot orthoses for preambulatory children with spastic diplegia. J Pediatr Orthop1977; 17: 370-376.
6.
Park ES, Park CI, Lee HJ, Kim DY, Lee DS, Cho SR. The characteristics of sit-to-stand transfer in young children with spastic cerebral palsy based on kinematic and kinetic data. Gait Posture2003; 17: 43-49.
7.
Cheng PT, Chen CL, Wang CM, Hong WH. Leg muscle activation patterns of sit-to-stand movement in stroke patients. Am J Phys Med Rehabil2004; 83: 10-16.
8.
Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol1993; 36: 386-396.
9.
Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T.Management of spasticity in cerebral palsy with botulinum toxin A: preliminary investigation. J Pediatr Orthop1993; 13: 489-495.
10.
Koman LA, Mooney JF, Mulvaney T, Roberts S, Smith BP. Further evaluation of botulinum toxin (Botox) in the management of cerebral palsy. Dev Med Child Neurol1993; 35: 29-30.
11.
Koman LAMooney JF, III, Smith BP, Goodman A, Mulvaney T.Management of spasticity in cerebral palsy with botulinum A toxin: report of a preliminary, randomized, double blind trial. J Pediatr Orthop1994; 14: 299-303.
12.
Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy; a 3-dimensional motion analysis study. Gait Posture1996; 4: 269-279.
13.
Thompson NS, Cosgrove IS, Graham HK. Musculoskeletal modeling in determining the effect of botulinum toxin on the hamstring of patients with crouch gait. Dev Med Child Neurol1998; 40: 622-625.
14.
Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounits SH. Randomized double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child2000; 83: 481-487.
15.
Bohannon RW, Smith MB, Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther1987; 67: 206-207.
16.
Lee MY, Wong MK, Tang FT, Cheng PT, Lin PS. Comparison of balance responses and motor patterns during sit-to-stand task with functional mobility in stroke patients. Am J Phys Med Rehabil1997; 76: 401-410.
17.
Chou WS, Wong AMK, Leong CP, Hong WS, Tang FT, Lin TH. Postural control during sit-to-stand and gait in stroke patients. Am J Phys Med Rehabil2003; 82: 42-47.
18.
Hesse S, Brandl-Hesse B, Seidel U, Doll B, Gregoric M.Lower limb muscle activity in ambulatory children with cerebral palsy before and after the treatment with botulinum toxin A. Restor Neurol Neurosci2000; 17: 1-8.
19.
Hesse S, Kranjnik K, Luecke D, Jahnke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke1996; 27: 455-460.
20.
Butler PB, Nene AV, Major RE. Biomechanics of transfer from sitting to the standing position in some neuromuscular diseases. Physiotherapy1991; 77: 521-525.
21.
Schultz AB, Alexander NB, Ashton-Miller JA. Biomechanical analysis of rising from a chair. J Biomech1992; 25: 1383-1391.
22.
Doorenbosch CAM, Harlaar J, Roebroeck ME, Lankhorst GJ. Two strategies of transferring from sit-to-stand; the activation of monoarticular and biarticular muscles. J Biomech1994; 27: 1299-1307.
23.
Pai YC, Rogers MW. Speed variation and resultant joint torques during sit-to-stand. Arch Phys Med Rehabil1991; 72: 881-885.
24.
Mark MK, Hui-Chan CW. The speed of sit-to-stand can be modulated in Parkinson's disease. Clin Neurophysiol2005; 116: 780-789.
